Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations

PURPOSE: The activation of the mitogen-activated protein kinase (MAPK) pathway has been suggested as the major downstream target when GNAQ and GNA11 (GNAQ/11) are mutated in uveal melanoma (UM). However, clinical trials with single agent MEK inhibitor showed no clinical significance in altering the...

Descripción completa

Detalles Bibliográficos
Autores principales: Boru, Getachew, Cebulla, Colleen M., Sample, Klarke M., Massengill, James B., Davidorf, Frederick H., Abdel-Rahman, Mohamed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Anatomy and Pathology/Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557618/
https://www.ncbi.nlm.nih.gov/pubmed/31173078
http://dx.doi.org/10.1167/iovs.18-26452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557618/
https://www.ncbi.nlm.nih.gov/pubmed/31173078
http://dx.doi.org/10.1167/iovs.18-26452

Ejemplares similares